Published in Gastroenterol Clin Biol on January 01, 1995
Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet (2001) 5.82
Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature (1996) 5.44
Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis (2009) 4.72
Effects of cigarette smoking on the long-term course of Crohn's disease. Gastroenterology (1996) 2.61
Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery. Gut (2005) 2.33
The impact of cytomegalovirus reactivation and its treatment on the course of inflammatory bowel disease. Aliment Pharmacol Ther (2014) 2.09
Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIV coinfected subjects: an early report. Gut (2000) 1.94
European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults. HIV Med (2008) 1.84
Smoking cessation and the course of Crohn's disease: an intervention study. Gastroenterology (2001) 1.73
Natural history of HCV infection. Baillieres Best Pract Res Clin Gastroenterol (2000) 1.61
Effect of indinavir on HIV-related wasting. AIDS (1998) 1.59
Oral contraceptive use and the clinical course of Crohn's disease: a prospective cohort study. Gut (1999) 1.56
The clinicopathological features of extensive small intestinal CD4 T cell infiltration. Gut (1999) 1.54
Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther (2001) 1.52
Effect of antibiotic therapy on human fecal microbiota and the relation to the development of Clostridium difficile. Microb Ecol (2008) 1.51
Macronutrient intake and malabsorption in HIV infection: a comparison with other malabsorptive states. Gut (1997) 1.46
Crohn's disease clinical course and severity in obese patients. Clin Nutr (2002) 1.40
[Anticoagulant clinics are they effective in France? Performance evaluation of six anticoagulant clinics concerning the management of vitamin K antagonists]. Rev Med Interne (2013) 1.39
Variability of the area under the receiver operating characteristic curves in the diagnostic evaluation of liver fibrosis markers: impact of biopsy length and fragmentation. Aliment Pharmacol Ther (2007) 1.38
Effects of current and former cigarette smoking on the clinical course of Crohn's disease. Aliment Pharmacol Ther (1999) 1.27
The role of anatomic factors in nutritional autonomy after extensive small bowel resection. JPEN J Parenter Enteral Nutr (1997) 1.26
Effects of appendicectomy on the course of ulcerative colitis. Gut (2002) 1.24
Efficacy of lamivudine on replication of hepatitis B virus in HIV-infected patients. Lancet (1995) 1.22
Therapeutic issues in HIV/HCV-coinfected patients. J Viral Hepat (2007) 1.20
Systemic lupus erythematosus and chronic intestinal pseudoobstruction. J Rheumatol (1993) 1.08
Multicentre study of hepatitis B virus genotypes in France: correlation with liver fibrosis and hepatitis B e antigen status. J Viral Hepat (2006) 1.06
Incidence of benign upper respiratory tract infections, HSV and HPV cutaneous infections in inflammatory bowel disease patients treated with azathioprine. Aliment Pharmacol Ther (2009) 1.04
Linkage analyses of chromosome 6 loci, including HLA, in familial aggregations of Crohn disease. G.E.T.A.I.D. Am J Med Genet (1994) 1.02
An independent and prospective comparison of two commercial fibrosis marker panels (HCV FibroSURE and FIBROSpect II) during albinterferon alfa-2b combination therapy for chronic hepatitis C. J Viral Hepat (2008) 1.02
Impact of pregnancy on the clinical activity of Crohn's disease. Aliment Pharmacol Ther (2005) 0.99
Hepatitis B virus (HBV) mutations associated with resistance to lamivudine in patients coinfected with HBV and human immunodeficiency virus. J Clin Microbiol (1999) 0.97
Classification of the sequelae of bowel resection for Crohn's disease. Br J Surg (1994) 0.97
Symptomatic response to varying levels of fructo-oligosaccharides consumed occasionally or regularly. Eur J Clin Nutr (1995) 0.95
Inflammatory bowel disease and lymphoproliferative disorders: the dust is starting to settle. Gut (2009) 0.95
Treatment of AIDS-associated gastrointestinal cytomegalovirus infection with foscarnet and ganciclovir: a randomized comparison. J Infect Dis (1995) 0.94
[Sclerosing peritonitis. A series of 10 cases and review of the literature]. Gastroenterol Clin Biol (1995) 0.93
Predictive factors of outcome of intensive intravenous treatment for attacks of ulcerative colitis. Aliment Pharmacol Ther (2000) 0.92
Methodological aspects of the interpretation of non-invasive biomarkers of liver fibrosis: a 2008 update. Gastroenterol Clin Biol (2008) 0.92
Impact of adefovir dipivoxil on liver fibrosis and activity assessed with biochemical markers (FibroTest-ActiTest) in patients infected by hepatitis B virus. J Viral Hepat (2008) 0.92
Crohn's disease severity in familial and sporadic cases. Gut (1999) 0.91
Low prevalence of colonoscopic surveillance of inflammatory bowel disease patients with longstanding extensive colitis: a clinical practice survey nested in the CESAME cohort. Aliment Pharmacol Ther (2011) 0.91
Successful control of subfulminant hepatitis related to lamivudine-resistant hepatitis B virus in an HIV-infected patient. AIDS (2001) 0.89
[Effect of smoking on the long-term course of ulcerative colitis]. Gastroenterol Clin Biol (1998) 0.89
Adaptive hyperphagia in patients with postsurgical malabsorption. Gastroenterology (1990) 0.89
Impact of human immunodeficiency virus infection on the histological features of chronic hepatitis C: a case-control study. The MULTIVIRC group. Hum Pathol (2000) 0.88
Non-steroidal anti-inflammatory drugs as a risk factor for acute diarrhoea: a case crossover study. Gut (2003) 0.87
Colorectal neoplasia in Crohn's colitis: a retrospective comparative study with ulcerative colitis. Histopathology (2007) 0.86
Unsuccessful rescue therapy with adefovir dipivoxil for lamivudine resistant HBV in a patient with liver failure. Gut (2003) 0.85
Diagnosis and prognosis of AIDS-related cholangitis. AIDS (1995) 0.84
Natural variability of NS3 protease in patients infected with genotype 4 hepatitis C virus (HCV): implications for antiviral treatment using specifically targeted antiviral therapy for HCV. J Infect Dis (2009) 0.83
Severe acute pancreatitis related to the use of nelfinavir in HIV infection: report of a case with positive rechallenge. AIDS (1999) 0.82
Kinetics of mucosal ileal gamma-interferon response during cryptosporidiosis in immunocompetent neonatal mice. Parasitol Res (1996) 0.82
[Comparison of long-term course of perforating and non-perforating Crohn disease]. Gastroenterol Clin Biol (1999) 0.82
Reversal of abnormal collagen production in Crohn's disease intestinal biopsies treated with regenerating agents. Gut (2004) 0.82
Cryptosporidium parvum infection in suckling rats: impairment of mucosal permeability and Na(+)-glucose cotransport. Exp Parasitol (1999) 0.81
Irritable bowel syndrome is more frequent in patients hospitalized for ischaemic colitis: results of a case-control study. Neurogastroenterol Motil (2009) 0.81
[Treatment of chronic hepatitis B in HIV co-infected patients]. Gastroenterol Clin Biol (2008) 0.81
Evaluation of metal contamination in sediments from north of Morocco: geochemical and statistical approaches. Environ Monit Assess (2008) 0.80
Flumazenil therapy for hepatic encephalopathy in cirrhotic patients: a double-blind pragmatic randomized, placebo study. Eur J Gastroenterol Hepatol (1995) 0.80
Intestinal histoplasmosis in AIDS patients: report of three cases observed in France and review of the literature. Eur J Gastroenterol Hepatol (1995) 0.80
Comparative value of colonic biopsy and intraluminal fluid culture for diagnosis of bacterial acute colitis in immunocompetent patients. Infectious Colitis Study Group. Clin Infect Dis (1999) 0.80
Hypnotic relaxation: a new sedative tool for colonoscopy? J Clin Gastroenterol (1994) 0.79
Genetic heterogeneity of the hypervariable region I of Hepatitis C virus and lymphoproliferative disorders. Leukemia (2005) 0.79
Improvement in protein absorption with a small-peptide-based diet in patients with high jejunostomy. Nutrition (1993) 0.79
Gastrointestinal bleeding diagnosed using video capsule endoscopy. Meckel's diverticulum. Gut (2009) 0.78
Absorption of zidovudine in patients with diarrhoea. Eur J Clin Pharmacol (1993) 0.78
A high-yield outbred suckling mouse model of cryptosporidiosis. Parasite (1995) 0.78
[Helicobacter pylori prevalence in Raynaud's disease]. Rev Med Interne (2006) 0.78
Impact of interferon-alpha treatment on liver fibrosis in patients with chronic hepatitis B: an overview of published trials. Gastroenterol Clin Biol (2009) 0.78
[Long-term therapy for chronic hepatitis B in HIV co-infected patients]. Gastroenterol Clin Biol (2010) 0.78
[Prevalence and role of anticardiolipin antibodies in Crohn disease]. Gastroenterol Clin Biol (1996) 0.77
Epithelial apoptosis as a very early marker of drug-induced colitis: the example of ranitidine. Gastroenterol Clin Biol (1996) 0.77
Risk factors of acute diarrhoea in summer--a nation-wide French case-control study. Epidemiol Infect (2000) 0.77
The phospholipids in Enterocytozoon bieneusi: an electron spectroscopic imaging study. Folia Parasitol (Praha) (1993) 0.77
[Functional diarrheas are not, in most cases, minor clinical forms of lymphocytic or collagenous colitis]. Gastroenterol Clin Biol (1996) 0.76
FibroTest is effective in patients with normal transaminases, when accuracy is standardized on fibrosis stage prevalence. J Viral Hepat (2008) 0.75
Cyclospora sp:life cycle studies in patient by electron-microscopy. J Eukaryot Microbiol (1996) 0.75
[Microscopic colitis: nosological face-lift and research tracks]. Gastroenterol Clin Biol (2008) 0.75
[The clinical activity of Crohn's disease in the Paris area is maximal in the spring]. Ann Gastroenterol Hepatol (Paris) (1995) 0.75
[The Fitz-Hugh-Curtis syndrome. Apropos of an unusual hepatic ultrasonic aspect]. J Radiol (1984) 0.75
[Treatment and prevention of hepatitis C]. Rev Prat (2000) 0.75
[Assigning the cause of diarrhea and enterocolitis to drugs. Current approach and outlook for improvement]. Gastroenterol Clin Biol (1998) 0.75
[Multifocal inflammatory leukoencephalopathy: a complication of chemotherapy by fluorouracil and levamisole]. Rev Neurol (Paris) (1995) 0.75
[Lamprene in ano-perineal lesions of Crohn's disease. A retrospective study]. Ann Gastroenterol Hepatol (Paris) (1993) 0.75
[A rare cause of chronic diarrhea]. Rev Med Interne (1997) 0.75
[Contribution of telemedicine applied to digestive cancer]. Gastroenterol Clin Biol (1999) 0.75
[Epidemiology of Crohn disease in Public Assistance-Hospitals in Paris. Data of hospitalizations 1981-1992]. Gastroenterol Clin Biol (1996) 0.75
[The risk of extra-colonic extension in Crohn's colitis]. Ann Gastroenterol Hepatol (Paris) (1993) 0.75
[Severe gastrointestinal hemorrhage secondary to diffuse angiodysplasia: efficacy of estrogen-progesterone treatment]. Presse Med (2000) 0.75
[Aspirin and temporal arteritis]. J Mal Vasc (2005) 0.75
[Effects of preoperative artificial nutrition in intestinal resections for Crohn disease]. Gastroenterol Clin Biol (1996) 0.75
[Anasarca caused by exudative enteropathy due to digestive Kaposi's sarcoma]. Presse Med (1989) 0.75
[Diffuse pain in a 40-year-old woman]. Rev Med Interne (2013) 0.75
[Role of interferons in the treatment of hepatitis B and hepatitis C virus infections]. Rev Med Interne (2002) 0.75
[Colonic involvement in ileal Crohn's disease]. Gastroenterol Clin Biol (1999) 0.75
Search for asymptomatic coeliac disease in patients with spongiform encephalopathy. Gastroenterol Clin Biol (1999) 0.75
[Treatment of Crohn disease in adults]. Rev Med Interne (1994) 0.75
[Endoscopy of chronic inflammatory intestinal diseases: importance for surveillance]. Gastroenterol Clin Biol (1999) 0.75
[Prognosis in pancolonic forms of hemorrhagic rectocolitis]. Gastroenterol Clin Biol (1996) 0.75
[Care patterns and resumption of social and occupational activities after exeresis surgery in Crohn's disease. Study of 58 patients]. Ann Gastroenterol Hepatol (Paris) (1995) 0.75